

Profil
Michel Finance currently works at Holding Incubatrice Biotechnologie, as Chairman & Chief Executive Officer, Prestizia SASU, as Chairman, France Biotech Association, as Director from 2006, and Truffle Capital SAS, as Venture Partner from 2010.
Mr. Finance also formerly worked at Theradiag SA, as CEO, Director & Head-Investor Relations in 2013, Zophis SASU, as Chairman, Biokinesis SAS, as Chairman, Affluent Medical SA, as Executive Chairman from 2022 to 2023, Flamel Technologies SA, as Deputy Managing Director in 2008, Sanofi, as Financial Director, Neovacs SA, as Executive Director from 2009 to 2015, Carmat SA, as Independent Director from 2008 to 2015, Aventis, Inc., as Controller & Senior Vice President, and PricewaterhouseCoopers Audit SA, as Financial Auditor.
Mr. Finance received his undergraduate degree from EM Lyon Business School.
Dernières actualités sur Michel Finance
Postes actifs de Michel Finance
| Sociétés | Poste | Début |
|---|---|---|
France Biotech Association
France Biotech Association Miscellaneous Commercial ServicesCommercial Services Operates an organisation for growth of health industry | Directeur/Membre du Conseil | 06/08/2010 |
Truffle Capital SAS
Truffle Capital SAS Investment ManagersFinance Truffle Capital invests in companies located in France with revenues of EUR 5 million. The firm focuses on life sciences (medtech & biotech) and deeptech applied to finance (fintech & Insurtech) sectors. It provides financing for early stage capital requirements with an investment size of EUR 5 - 15 million. It acts as a lead investor and it takes a seat on the board of directors. The firm makes follow-on investments. | Analyste en capital-investissement | 01/01/2010 |
Prestizia SASU
Prestizia SASU Miscellaneous Commercial ServicesCommercial Services Provides biotechnology research and development services | Président | - |
Holding Incubatrice Biotechnologie
Holding Incubatrice Biotechnologie Investment ManagersFinance Acts as Venture Capital Fund | Directeur Général | - |
Anciens postes connus de Michel Finance
| Sociétés | Poste | Fin |
|---|---|---|
Affluent Medical SA
Affluent Medical SA Medical SpecialtiesHealth Technology Develops and manufactures minimally invasive prostheses | Directeur Général | 22/08/2022 |
| THERADIAG | Directeur Général | 31/12/2018 |
| NEOVACS | Directeur/Membre du Conseil | 05/06/2015 |
| CARMAT SA | Directeur/Membre du Conseil | 20/03/2015 |
Flamel Technologies SA
Flamel Technologies SA Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Corporate Officer/Principal | 01/01/2008 |
Formation de Michel Finance
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 15 |
|---|---|
Flamel Technologies SA
Flamel Technologies SA Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Health Technology |
Sanofi
Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
Aventis, Inc.
Aventis, Inc. MiscellaneousMiscellaneous Functions as an investment holding company | Miscellaneous |
Theradiag SA
Theradiag SA Medical SpecialtiesHealth Technology Develops, manufactures and markets in-vitro diagnostic products | Health Technology |
Neovacs SA
Neovacs SA Pharmaceuticals: MajorHealth Technology Discovers and develops antibody therapies | Health Technology |
EM Lyon Business School
EM Lyon Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PricewaterhouseCoopers Audit SAS
PricewaterhouseCoopers Audit SAS Miscellaneous Commercial ServicesCommercial Services Provides accounting, auditing, tax and cloud transformation consulting services | Commercial Services |
France Biotech Association
France Biotech Association Miscellaneous Commercial ServicesCommercial Services Operates an organisation for growth of health industry | Commercial Services |
Truffle Capital SAS
Truffle Capital SAS Investment ManagersFinance Truffle Capital invests in companies located in France with revenues of EUR 5 million. The firm focuses on life sciences (medtech & biotech) and deeptech applied to finance (fintech & Insurtech) sectors. It provides financing for early stage capital requirements with an investment size of EUR 5 - 15 million. It acts as a lead investor and it takes a seat on the board of directors. The firm makes follow-on investments. | Finance |
Carmat SA
Carmat SA Medical SpecialtiesHealth Technology Specializes in the construction of artificial hearts | Health Technology |
Holding Incubatrice Biotechnologie
Holding Incubatrice Biotechnologie Investment ManagersFinance Acts as Venture Capital Fund | Finance |
Prestizia SASU
Prestizia SASU Miscellaneous Commercial ServicesCommercial Services Provides biotechnology research and development services | Commercial Services |
Zophis SASU
Zophis SASU BiotechnologyHealth Technology Operates as a holding company with interest in developing vaccine products | Health Technology |
Biokinesis SAS
Biokinesis SAS BiotechnologyHealth Technology Engages in research and development of oncology drugs | Health Technology |
Affluent Medical SA
Affluent Medical SA Medical SpecialtiesHealth Technology Develops and manufactures minimally invasive prostheses | Health Technology |
















